| CD133+ and CD133− Glioblastoma-Derived Cancer Stem Cells Show Differential Growth Characteristics and Molecular Profiles D Beier, P Hau, M Proescholdt, A Lohmeier, J Wischhusen, PJ Oefner, ... Cancer research 67 (9), 4010-4015, 2007 | 1478 | 2007 |
| Expression of the B7-related molecule B7-H1 by glioma cells: a potential mechanism of immune paralysis S Wintterle, B Schreiner, M Mitsdoerffer, D Schneider, L Chen, ... Cancer research 63 (21), 7462-7467, 2003 | 507 | 2003 |
| Temozolomide preferentially depletes cancer stem cells in glioblastoma D Beier, S Röhrl, DR Pillai, S Schwarz, LA Kunz-Schughart, P Leukel, ... Cancer research 68 (14), 5706-5715, 2008 | 396 | 2008 |
| Chemoresistance of glioblastoma cancer stem cells-much more complex than expected D Beier, JB Schulz, CP Beier Molecular cancer 10, 1-11, 2011 | 375 | 2011 |
| Transcriptional Profiles of CD133+ and CD133− Glioblastoma-Derived Cancer Stem Cell Lines Suggest Different Cells of Origin C Lottaz, D Beier, K Meyer, P Kumar, A Hermann, J Schwarz, M Junker, ... Cancer research 70 (5), 2030-2040, 2010 | 305 | 2010 |
| CAMTA1 is a novel tumour suppressor regulated by miR‐9/9* in glioblastoma stem cells D Schraivogel, L Weinmann, D Beier, G Tabatabai, A Eichner, JY Zhu, ... The EMBO journal 30 (20), 4309-4322, 2011 | 200 | 2011 |
| CD133 expression and cancer stem cells predict prognosis in high‐grade oligodendroglial tumors D Beier, J Wischhusen, W Dietmaier, P Hau, M Proescholdt, A Brawanski, ... Brain pathology 18 (3), 370-377, 2008 | 187 | 2008 |
| Immunoselection of breast and ovarian cancer cells with trastuzumab and natural killer cells: selective escape of CD44high/CD24low/HER2low breast cancer stem cells F Reim, Y Dombrowski, C Ritter, M Buttmann, S Häusler, M Ossadnik, ... Cancer research 69 (20), 8058-8066, 2009 | 165 | 2009 |
| Muscle fibres and cultured muscle cells express the B7. 1/2‐related inducible co‐stimulatory molecule, ICOSL: implications for the pathogenesis of inflammatory myopathies H Wiendl, M Mitsdoerffer, D Schneider, A Melms, H Lochmuller, ... Brain 126 (5), 1026-1035, 2003 | 160 | 2003 |
| Human muscle cells express a B7‐related molecule, B7‐H1, with strong negative immune regulatory potential: a novel mechanism of counterbalancing the immune attack in idiopathic … H Wiendl, M Mitsdoerffer, D Schneider, L Chen, H Lochmüller, A Melms, ... The FASEB journal 17 (13), 1-16, 2003 | 142 | 2003 |
| RNOP-09: pegylated liposomal doxorubicine and prolonged temozolomide in addition to radiotherapy in newly diagnosed glioblastoma-a phase II study CP Beier, C Schmid, T Gorlia, C Kleinletzenberger, D Beier, O Grauer, ... BMC cancer 9, 1-10, 2009 | 109 | 2009 |
| Glioblastoma cancer stem cells–from concept to clinical application BE Stopschinski, CP Beier, D Beier Cancer letters 338 (1), 32-40, 2013 | 104 | 2013 |
| The cancer stem cell subtype determines immune infiltration of glioblastoma CP Beier, P Kumar, K Meyer, P Leukel, V Bruttel, I Aschenbrenner, ... Stem cells and development 21 (15), 2753-2761, 2012 | 91 | 2012 |
| Intracellular acidification by inhibition of the Na+/H+-exchanger leads to caspase-independent death of cerebellar granule neurons resembling paraptosis D Schneider, E Gerhardt, J Bock, MM Müller, H Wolburg, F Lang, ... Cell Death & Differentiation 11 (7), 760-770, 2004 | 77 | 2004 |
| EANO–EURACAN clinical practice guideline for diagnosis, treatment, and follow-up of post-pubertal and adult patients with medulloblastoma E Franceschi, S Hofer, AA Brandes, D Frappaz, RD Kortmann, ... The Lancet Oncology 20 (12), e715-e728, 2019 | 73 | 2019 |
| Multicenter pilot study of radiochemotherapy as first-line treatment for adults with medulloblastoma (NOA-07) D Beier, M Proescholdt, C Reinert, T Pietsch, DTW Jones, SM Pfister, ... Neuro-oncology 20 (3), 400-410, 2018 | 73 | 2018 |
| Chemotherapy increases long-term survival in patients with adult medulloblastoma—a literature-based meta-analysis S Kocakaya, CP Beier, D Beier Neuro-oncology 18 (3), 408-416, 2015 | 71 | 2015 |
| Chemoresistance and chemotherapy targeting stem-like cells in malignant glioma MD Sørensen, S Fosmark, S Hellwege, D Beier, BW Kristensen, CP Beier Stem Cell Biology in Neoplasms of the Central Nervous System, 111-138, 2015 | 59 | 2015 |
| CD133 negative cancer stem cells in glioblastoma CP Beier, D Beier Front Biosci (Elite Ed) 3 (2), 701-710, 2011 | 58 | 2011 |
| YB-1 dependent oncolytic adenovirus efficiently inhibits tumor growth of glioma cancer stem like cells K Mantwill, U Naumann, J Seznec, V Girbinger, H Lage, P Surowiak, ... Journal of translational medicine 11, 1-13, 2013 | 56 | 2013 |
